Dermatitis herpetiformis secondary prevention

Dermatitis herpetiformis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dermatitis herpetiformis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dermatitis herpetiformis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dermatitis herpetiformis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dermatitis herpetiformis secondary prevention
CDC on Dermatitis herpetiformis secondary prevention
Dermatitis herpetiformis secondary prevention in the news
Blogs on Dermatitis herpetiformis secondary prevention
Directions to Hospitals Treating Dermatitis herpetiformis
Risk calculators and risk factors for Dermatitis herpetiformis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Secondary Prevention

Strict adherence to gluten free diet and dapsone, should improve the symptoms in few days of initiation of treatment. After tapering of dapsone, patient should be instructed to continue gluten free diet because it prevents the reappearance of symptoms and complications of celiac disease .